Tirzepatide Lyophilized High Purity 99% Peptide Powder TR 10mg 15mg 20mg 30mg pa vial ya shuga / shuga

Tirzepatide ndi mtundu waposachedwa wa insulinotropic polypeptide/glucagon-ngati peptide 1 (GLP-1) receptor agonist wovomerezedwa ku United States ngati chothandizira pazakudya ndi masewera olimbitsa thupi kuti apititse patsogolo kuwongolera kwa glycemic mwa akuluakulu omwe ali ndi matenda a shuga amtundu wa 2 komanso akufufuzidwa kuti agwiritsidwe ntchito pakuwongolera kulemera kwanthawi yayitali, zovuta zazikulu zamtima ndi kuwongolera zochitika zamtima, kuphatikiza kulephera kwamtima ndi zina zosungidwa. non-cirrhotic non-alcohol steatohepatitis. Pulogalamu yachipatala ya Phase 3 SURPASS 1-5 idapangidwa kuti iwonetse mphamvu ndi chitetezo cha tirzepatide kamodzi pa sabata (5, 10 ndi 15 mg), monga monotherapy kapena kuphatikiza mankhwala, mwa anthu ambiri omwe ali ndi matenda a shuga a 2. Kugwiritsa ntchito tirzepatide m'maphunziro azachipatala kunalumikizidwa ndi kuchepa kwakukulu kwa hemoglobin ya glycated (-1.87 mpaka -2.59%, -20 mpaka -28 mmol/mol) ndi kulemera kwa thupi (-6.2 mpaka -12.9 kg), komanso kuchepa kwa magawo omwe nthawi zambiri amakhudzana ndi kuchulukitsidwa kwachiwopsezo chamtima monga kuthamanga kwa magazi, triglycerides ndi triglycerides. Tirzepatide idalekerera bwino, yokhala ndi chiwopsezo chochepa cha hypoglycemia ikagwiritsidwa ntchito popanda insulin kapena insulin secretagogues ndipo imawonetsa chitetezo chofanana ndi gulu la GLP-1 receptor agonist. Chifukwa chake, umboni wochokera m'mayesero azachipatalawa ukuwonetsa kuti tirzepatide imapereka mwayi watsopano wotsitsa hemoglobin ya glycated ndi kulemera kwa thupi mwa akulu omwe ali ndi matenda amtundu wa 2.